Food allergy: Mechanisms and therapeutics

Current Opinion in Immunology

Volumn 23, Issue 6, 2011, Pages 794-800

  Berin, M Cecilia ^a   Sicherer, Scott ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHINESE DRUG; CYTOKINE; CYTOKINE ANTIBODY; FOOD ALLAERGY HERBAL FORMULA 2; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 9; MILK PROTEIN; MODIFIED PROTEIN VACCINE; OMALIZUMAB; PEANUT PROTEIN; PEPTIDE VACCINE; PROBIOTIC AGENT; PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ALLERGENICITY; ANAPHYLAXIS; EPICUTANEOUS IMMUNOTHERAPY; FOOD ALLERGY; GASTROINTESTINAL MUCOSA; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INTESTINE EPITHELIUM CELL; MILK ALLERGY; MUCOSAL IMMUNITY; NONHUMAN; ORAL IMMUNOTHERAPY; PATHOPHYSIOLOGY; PEANUT ALLERGY; REVIEW; SENSITIZATION; SUBLINGUAL IMMUNOTHERAPY;

ANAPHYLAXIS; ANIMALS; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOGLOBULIN E;

EID: 82955239774     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.08.010     Document Type: Review

References (51)

1. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A., Plaut M., Cooper S.F., Fenton M.J., Arshad S.H., et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 2010, 126:S1-S58.
2. Hadis U., Wahl B., Schulz O., Hardtke-Wolenski M., Schippers A., Wagner N., Muller W., Sparwasser T., Forster R., Pabst O. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011, 34:237-246.
3. Shreffler W.G., Wanich N., Moloney M., Nowak-Wegrzyn A., Sampson H.A. Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009, 123:43-52. e47.
4. Zhou Y., Kawasaki H., Hsu S.C., Lee R.T., Yao X., Plunkett B., Fu J., Yang K., Lee Y.C., Huang S.K. Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med 2010, 16:1128-1133.
5. Fox A.T., Sasieni P., du Toit G., Syed H., Lack G. Household peanut consumption as a risk factor for the development of peanut allergy. J Allergy Clin Immunol 2009, 123:417-423.
6. Brown S.J., Asai Y., Cordell H.J., Campbell L.E., Zhao Y., Liao H., Northstone K., Henderson J., Alizadehfar R., Ben-Shoshan M., et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011, 127:661-667.
7. Oyoshi M.K., Murphy G.F., Geha R.S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009, 124:485-493. 493 e481.
8. Parvataneni S., Gonipeta B., Tempelman R.J., Gangur V. Development of an adjuvant-free cashew nut allergy mouse model. Int Arch Allergy Immunol 2009, 149:299-304.
9. Mondoulet L., Dioszeghy V., Vanoirbeek J.A., Nemery B., Dupont C., Benhamou P.H. Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts. Int Arch Allergy Immunol 2011, 154:299-309.
10. Dunkin D., Berin M.C., Mayer L. Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner. J Allergy Clin Immunol 2011, Jul 13. [Epub ahead of print].
11. Pochard P., Vickery B., Berin M.C., Grishin A., Sampson H.A., Caplan M., Bottomly K. Targeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro. J Allergy Clin Immunol 2010, 126:92-97. e95.
12. Khodoun M., Strait R., Orekov T., Hogan S., Karasuyama H., Herbert D.R., Kohl J., Finkelman F.D. Peanuts can contribute to anaphylactic shock by activating complement. J Allergy Clin Immunol 2009, 123:342-351.
13. Jyonouchi S., Abraham V., Orange J.S., Spergel J.M., Gober L., Dudek E., Saltzman R., Nichols K.E., Cianferoni A. Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin. J Allergy Clin Immunol 2011, 128:102-109. e113.
14. Hilmenyuk T., Bellinghausen I., Heydenreich B., Ilchmann A., Toda M., Grabbe S., Saloga J. Effects of glycation of the model food allergen ovalbumin on antigen uptake and presentation by human dendritic cells. Immunology 2010, 129:437-445.
15. Ilchmann A., Burgdorf S., Scheurer S., Waibler Z., Nagai R., Wellner A., Yamamoto Y., Yamamoto H., Henle T., Kurts C., et al. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J Allergy Clin Immunol 2010, 125:175-183. e171-111.
16. Masilamani M., Wei J., Bhatt S., Paul M., Yakir S., Sampson H.A. Soybean isoflavones regulate dendritic cell function and suppress allergic sensitization to peanut. J Allergy Clin Immunol 2011, Jun 20. [Epub ahead of print].
17. Chen X., Song C.H., Liu Z.Q., Feng B.S., Zheng P.Y., Li P., In S.H., Tang S.G., Yang P.C. Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine. Allergy 2011, 66:1038-1046.
18. Blazquez A.B., Mayer L., Berin M.C. Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. Gastroenterology 2010, 139:1301-1309.
19. Rothenberg M.E., Spergel J.M., Sherrill J.D., Annaiah K., Martin L.J., Cianferoni A., Gober L., Kim C., Glessner J., Frackelton E., et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010, 42:289-291.
20. Prussin C., Lee J., Foster B. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol 2009, 124:1326-1332. e1326.
21. DeLong J.H., Simpson K.H., Wambre E., James E.A., Robinson D., Kwok W.W. Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol 2011, 127:1211-1218. e1213.
22. Mathias C.B., Hobson S.A., Garcia-Lloret M., Lawson G., Poddighe D., Freyschmidt E.J., Xing W., Gurish M.F., Chatila T.A., Oettgen H.C. IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling. J Allergy Clin Immunol 2011, 127:795-805. e791-796.
23. Wang M., Takeda K., Shiraishi Y., Okamoto M., Dakhama A., Joetham A., Gelfand E.W. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway. J Allergy Clin Immunol 2010, 126:306-316. 316 e301-312.
24. Osterfeld H., Ahrens R., Strait R., Finkelman F.D., Renauld J.C., Hogan S.P. Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol 2010, 125:469-476. e462.
25. Wu D., Ahrens R., Osterfeld H., Noah T.K., Groschwitz K., Foster P.S., Steinbrecher K.A., Rothenberg M.E., Shroyer N.F., Matthaei K.I., et al. Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl-secretion. J Biol Chem 2011, 286:13357-13369.
26. Arias K., Baig M., Colangelo M., Chu D., Walker T., Goncharova S., Coyle A., Vadas P., Waserman S., Jordana M. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. J Allergy Clin Immunol 2009, 124:307-314.
27. Arias K., Chu D.K., Flader K., Botelho F., Walker T., Arias N., Humbles A.A., Coyle A.J., Oettgen H.C., Chang H.D., et al. Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice. J Allergy Clin Immunol 2011, 127:1552-1561. e1551.
28. Schouten B., van Esch B.C., van Thuijl A.O., Blokhuis B.R., Groot Kormelink T., Hofman G.A., Moro G.E., Boehm G., Arslanoglu S., Sprikkelman A.B., et al. Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins. J Allergy Clin Immunol 2010, 125:1308-1314.
29. Hitomi Y., Ebisawa M., Tomikawa M., Imai T., Komata T., Hirota T., Harada M., Sakashita M., Suzuki Y., Shimojo N., et al. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 2009, 124:779-785. e776.
30. Nowak-Wegrzyn A., Sampson H.A. Future therapies for food allergies. J Allergy Clin Immunol 2011, 127:558-573. quiz 574-555.
31. Sicherer S.H., Sampson H.A. Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med 2009, 60:261-277.
32. Vickery B.P., Scurlock A.M., Jones S.M., Burks A.W. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol 2011, 127:576-584. quiz 585-576.
33. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., Shreffler W.G., Steele P., Henry K.A., Adair M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124:292-300. e291-297.
34. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., Kamilaris J., Burks A.W. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009, 124:286-291. e281-286.
35. Varshney P., Steele P.H., Vickery B.P., Bird J.A., Thyagarajan A., Scurlock A.M., Perry T.T., Jones S.M., Burks A.W. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009, 124:1351-1352.
36. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., Hiegel A., Kamilaris J., Carlisle S., Yue X., et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011, 127:654-660.
37. Blumchen K., Ulbricht H., Staden U., Dobberstein K., Beschorner J., de Oliveira L.C., Shreffler W.G., Sampson H.A., Niggemann B., Wahn U., et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010, 126:83-91. e81.
38. Anagnostou K., Clark A., King Y., Islam S., Deighton J., Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 2011, 41:1273-1281.
39. Pajno G.B., Caminiti L., Ruggeri P., De Luca R., Vita D., La Rosa M., Passalacqua G. Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 2010, 105:376-381.
40. Narisety S.D., Skripak J.M., Steele P., Hamilton R.G., Matsui E.C., Burks A.W., Wood R.A. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009, 124:610-612.
41. Vickery B.P., Pons L., Kulis M., Steele P., Jones S.M., Burks A.W. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010, 105:444-450.
42. Kim E.H., Bird J.A., Kulis M., Laubach S., Pons L., Shreffler W., Steele P., Kamilaris J., Vickery B., Burks A.W. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011, 127:640-646. e641.
43. Wanich N., Nowak-Wegrzyn A., Sampson H.A., Shreffler W.G. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009, 123:789-794. e720.
44. Kim J.S., Nowak-Wegrzyn A., Sicherer S.H., Noone S., Moshier E.L., Sampson H.A. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011, 128:125-131. e122.
45. Mondoulet L., Dioszeghy V., Ligouis M., Dhelft V., Dupont C., Benhamou P.H. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy 2010, 40:659-667.
46. Dupont C., Kalach N., Soulaines P., Legoue-Morillon S., Piloquet H., Benhamou P.H. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010, 125:1165-1167.
47. Sampson H.A., Leung D.Y., Burks A.W., Lack G., Bahna S.L., Jones S.M., Wong D.A. A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 2011, 127:1309-1310. e1301.
48. Wang J., Patil S.P., Yang N., Ko J., Lee J., Noone S., Sampson H.A., Li X.M. Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol 2010, 105:75-84.
49. Srivastava K.D., Qu C., Zhang T., Goldfarb J., Sampson H.A., Li X.M. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells. J Allergy Clin Immunol 2009, 123:443-451.
50. Song Y., Qu C., Srivastava K., Yang N., Busse P., Zhao W., Li X.M. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. J Allergy Clin Immunol 2010, 126:1208-1217. e1203.
51. Nadeau K.C., Schneider L.C., Hoyte L., Borras I., Umetsu D.T. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011, 127:1622-1624.